Multimodal Identification of Disease Segments

Thursday, January 28, 2027 at 4:40 PM to 5:10 PM · 30 min. (Europe/London)
AI in Drug Discovery Stage
Day 2 - Thursday 28th January
AIAI in Drug DiscoveryDrug DiscoveryMulti-Omics

Information

  • Explore how machine learning applied to large-scale plasma proteomics datasets can identify clinically meaningful disease segments and patient subtypes that are not captured by traditional diagnostic approaches.  
  • Demonstrate how proteomic signatures can be used to characterise disease heterogeneity, improve patient stratification, and support earlier diagnosis and precision medicine decision-making.